Additionally, we selected TSPAN4 with the best prognostic performance for experimental validation and demonstrated that the proliferation, invasion, and migration of glioma cells were significantly inhibited after TSPAN4 knockdown. Here, TSPAN4 is linked to central nervous system cancer.